Interleukin-6–Induced Inhibition of Multiple Myeloma Cell Apoptosis: Support for the Hypothesis That Protection Is Mediated Via Inhibition of the JNK/SAPK Pathway
Open Access
- 1 July 1998
- journal article
- Published by American Society of Hematology in Blood
- Vol. 92 (1) , 241-251
- https://doi.org/10.1182/blood.v92.1.241.413k28_241_251
Abstract
The mechanism by which interleukin-6 (IL-6) protects multiple myeloma (MM) plasma cells from apoptosis induced by anti-fas antibodies and dexamethasone was studKeywords
This publication has 44 references indexed in Scilit:
- Rapamycin Potentiates Dexamethasone-Induced Apoptosis and Inhibits JNK Activity in Lymphoblastoid CellsBiochemical and Biophysical Research Communications, 1997
- Induction of Apoptosis by ASK1, a Mammalian MAPKKK That Activates SAPK/JNK and p38 Signaling PathwaysScience, 1997
- Dissection of TNF Receptor 1 Effector Functions: JNK Activation Is Not Linked to Apoptosis While NF-κB Activation Prevents Cell DeathCell, 1996
- Opposing Effects of ERK and JNK-p38 MAP Kinases on ApoptosisScience, 1995
- R-Ras promotes apoptosis caused by growth factor deprivation via a Bcl-2 suppressible mechanism.The Journal of cell biology, 1995
- Interleukin-6 Inhibits Apoptosis of Malignant Plasma CellsCellular Immunology, 1995
- Ras-dependent growth factor regulation of MEK kinase in PC12 cellsScience, 1994
- The stress-activated protein kinase subfamily of c-Jun kinasesNature, 1994
- Transcription Factors′ DNA-Binding Activity in Rat Thymocytes Undergoing Apoptosis after Heat-Shock or Dexamethasone TreatmentBiochemical and Biophysical Research Communications, 1993
- Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factorCell, 1987